JP2007519618A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007519618A5 JP2007519618A5 JP2006542008A JP2006542008A JP2007519618A5 JP 2007519618 A5 JP2007519618 A5 JP 2007519618A5 JP 2006542008 A JP2006542008 A JP 2006542008A JP 2006542008 A JP2006542008 A JP 2006542008A JP 2007519618 A5 JP2007519618 A5 JP 2007519618A5
- Authority
- JP
- Japan
- Prior art keywords
- fluoro
- hydrogen
- independently selected
- cycloalkyl
- methoxymethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000001153 fluoro group Chemical group F* 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0328178.9A GB0328178D0 (en) | 2003-12-05 | 2003-12-05 | Compounds |
| PCT/GB2004/005068 WO2005056530A1 (en) | 2003-12-05 | 2004-12-02 | Benzoyl amino pyridyl carboxylic acid derivatives useful as glucokinase (glk) activators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007519618A JP2007519618A (ja) | 2007-07-19 |
| JP2007519618A5 true JP2007519618A5 (enExample) | 2007-09-27 |
Family
ID=29764609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006542008A Withdrawn JP2007519618A (ja) | 2003-12-05 | 2004-12-02 | グルコキナーゼ（ｇｌｋ）活性化剤として有用なベンゾイルアミノピリジルカルボン酸誘導体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20090062351A1 (enExample) |
| EP (1) | EP1697325A1 (enExample) |
| JP (1) | JP2007519618A (enExample) |
| CN (1) | CN1890219A (enExample) |
| GB (1) | GB0328178D0 (enExample) |
| WO (1) | WO2005056530A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
| SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| GB0226930D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| GB0226931D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| EP1718624B1 (en) * | 2004-02-18 | 2009-03-25 | AstraZeneca AB | Benzamide derivatives and their use as glucokinase activating agents |
| TW200600086A (en) * | 2004-06-05 | 2006-01-01 | Astrazeneca Ab | Chemical compound |
| TW200714597A (en) * | 2005-05-27 | 2007-04-16 | Astrazeneca Ab | Chemical compounds |
| NZ564608A (en) | 2005-07-09 | 2009-09-25 | Astrazeneca Ab | Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| AU2006299091A1 (en) | 2005-09-29 | 2007-04-12 | Sanofi-Aventis | Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
| CN101437512A (zh) * | 2006-01-27 | 2009-05-20 | 阿雷生物药品公司 | 葡萄糖激酶活化剂 |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| US7910747B2 (en) | 2006-07-06 | 2011-03-22 | Bristol-Myers Squibb Company | Phosphonate and phosphinate pyrazolylamide glucokinase activators |
| SA07280576B1 (ar) * | 2006-10-26 | 2011-06-22 | استرازينيكا ايه بي | مركبات بنزويل أمينو سيكليل غير متجانسة بأعتبارها عوامل منشطة للجلوكوكيناز |
| JP5572549B2 (ja) | 2007-08-13 | 2014-08-13 | リガンド・ファーマシューティカルズ・インコーポレイテッド | グルコキナーゼの新規な活性化剤 |
| GEP20135783B (en) * | 2008-05-16 | 2013-03-11 | Takeda California Inc | Glucokinase activators |
| JP2011529955A (ja) | 2008-08-04 | 2011-12-15 | アストラゼネカ アクチボラグ | 治療薬４１４ |
| GB0902406D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Crystalline polymorphic form |
| GB0902434D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Chemical process |
| WO2010116176A1 (en) * | 2009-04-09 | 2010-10-14 | Astrazeneca Ab | Pyrazolo [4, 5-e] pyrimidine derivative and its use to treat diabetes and obesity |
| WO2010116177A1 (en) | 2009-04-09 | 2010-10-14 | Astrazeneca Ab | A pyrazolo [4,5-e] pyrimidine derivative and its use to treat diabetes and obesity |
| WO2020037109A1 (en) * | 2018-08-17 | 2020-02-20 | Dow Agrosciences Llc | Processes for fluorination |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1437800A (en) * | 1973-08-08 | 1976-06-03 | Phavic Sprl | Derivatives of 2-benzamido-5-nitro-thiazoles |
| GB1561350A (en) * | 1976-11-05 | 1980-02-20 | May & Baker Ltd | Benzamide derivatives |
| US5466715A (en) * | 1991-12-31 | 1995-11-14 | Sterling Winthrop Inc. | 3,4-disubstituted phenols-immunomodulating agents |
| US5258407A (en) * | 1991-12-31 | 1993-11-02 | Sterling Winthrop Inc. | 3,4-disubstituted phenols-immunomodulating agents |
| AUPO395396A0 (en) * | 1996-12-02 | 1997-01-02 | Fujisawa Pharmaceutical Co., Ltd. | Benzamide derivatives |
| US6200995B1 (en) * | 1998-01-29 | 2001-03-13 | Tularik Inc. | PPAR-γ modulators |
| GB9811969D0 (en) * | 1998-06-03 | 1998-07-29 | Celltech Therapeutics Ltd | Chemical compounds |
| SE0102300D0 (sv) * | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
| SE0102299D0 (sv) * | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
| SE0102764D0 (sv) * | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| GB0226931D0 (en) * | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| GB0226930D0 (en) * | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| GB0325402D0 (en) * | 2003-10-31 | 2003-12-03 | Astrazeneca Ab | Compounds |
-
2003
- 2003-12-05 GB GBGB0328178.9A patent/GB0328178D0/en not_active Ceased
-
2004
- 2004-12-02 WO PCT/GB2004/005068 patent/WO2005056530A1/en not_active Ceased
- 2004-12-02 CN CNA2004800362365A patent/CN1890219A/zh active Pending
- 2004-12-02 JP JP2006542008A patent/JP2007519618A/ja not_active Withdrawn
- 2004-12-02 EP EP04801261A patent/EP1697325A1/en not_active Withdrawn
- 2004-12-02 US US10/579,782 patent/US20090062351A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007519618A5 (enExample) | ||
| JP2007508359A5 (enExample) | ||
| JP2005503385A5 (enExample) | ||
| JP2005523310A5 (enExample) | ||
| JP2007508362A5 (enExample) | ||
| JP2007519721A5 (enExample) | ||
| JP2009529540A5 (enExample) | ||
| JP2005507872A5 (enExample) | ||
| JP2006501292A5 (enExample) | ||
| JP2005539088A5 (enExample) | ||
| JP2011519854A5 (enExample) | ||
| JP2014507464A5 (enExample) | ||
| JP2007511546A5 (enExample) | ||
| JP2004083852A5 (enExample) | ||
| JP2007534702A5 (enExample) | ||
| CY1114932T1 (el) | Αντιπαρασιτικοι παραγοντες | |
| WO2005037781A3 (fr) | Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique | |
| JP2007518682A5 (enExample) | ||
| NO20075734L (no) | Tiofenforbindelser og trombopoietin reseptoractivatorer | |
| JP2005289914A5 (enExample) | ||
| JP2010520214A5 (enExample) | ||
| JP2013502441A5 (enExample) | ||
| JP2005536519A5 (enExample) | ||
| JP2005538089A5 (enExample) | ||
| JP2015512883A5 (enExample) |